![Hee-Deok Park](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 61 606 $ al 30/09/2026
Hee-Deok Park is currently Co-Chief Executive Officer & Director at PharmGen Science, Inc. since 2019.
Formerly, served as Director at Access Bio, Inc. Completed undergraduate education at Dong-A University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ACCESS BIO, INC. 0,11 % | 28/10/2025 | 39.332 ( 0,11 % ) | 61 606 $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| PHARMGEN SCIENCE, INC. | Director Ejecutivo | 27/03/2019 |
| Empresas | Cargo | Fin |
|---|---|---|
| ACCESS BIO, INC. | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
PharmGen Science, Inc.
 PharmGen Science, Inc. Pharmaceuticals: OtherHealth Technology Manufactures medicaments | Health Technology |
Dong-A University
 Dong-A University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Access Bio, Inc.
 Access Bio, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets in-vitro diagnostics tests | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
